The DTx Consortium is created to boost the adoption of digital therapies in Spain
Pharmaceutical, technology and telecommunications companies, startups and other entities have launched the DTx Consortium. It aims to advance the regulation of digital therapies and the definition of a sustainable financing model that guarantees their access to the Spanish healthcare market.
It’s the first Spanish multi-sector alliance focused on boosting the implementation of digital therapies in the national healthcare system. Spain is a country with enormous potential to adopt these types of solutions and thus take another step towards the digitalisation of the healthcare system, but to do so it is necessary to promote an effective regulatory model.
The members of the DTx Consortium are Barcelona Health Hub, Angelini Pharma España, Bayer, Boehringer Ingelheim, Ferrer, GSD Health, Merck España, Opinno, Pfizer España, IESE Business School, Teladoc Health, RocaJunyent, Unlimited Thinking, Vodafone Business, Vodafone Innovation Ecosystem, Amelia Virtual Care, Braingaze, Legit.Health and Onalabs Inno-Hub.
Read more about it here!